InvestorsHub Logo

DewDiligence

02/07/13 8:16 PM

#156661 RE: genisi #156606

This Globes piece on the Procognia-UniTargeting FoB collaboration is from Nov 2012:

http://www.biosimilarnews.com/procognia-expands-collaboration-with-unitargeting-research-for-biosimilars?thumb_date=2012-10-01

The article says the companies “will develop a biosimilar for a brand biological drug which currently has billions of dollars in annual sales.” Humira certainly qualifies on that score!

p.s. UTR is Norwegian, not Swedish.